App Description

The CSL Behring CSL300_2301 Phase 3 App is intended for use to collect patient reported outcomes relating to the CSL300_2301 Phase 3 clinical trial. Patients must be given accounts by a participating site in order to log in to the app

iPhone Screenshots

(click to enlarge)

CSL300_2301_Ph3 screenshot 1 CSL300_2301_Ph3 screenshot 2 CSL300_2301_Ph3 screenshot 3 CSL300_2301_Ph3 screenshot 4 CSL300_2301_Ph3 screenshot 5 CSL300_2301_Ph3 screenshot 6 CSL300_2301_Ph3 screenshot 7 CSL300_2301_Ph3 screenshot 8 CSL300_2301_Ph3 screenshot 9 CSL300_2301_Ph3 screenshot 10

iPad Screenshots

(click to enlarge)

CSL300_2301_Ph3 screenshot 11 CSL300_2301_Ph3 screenshot 12 CSL300_2301_Ph3 screenshot 13 CSL300_2301_Ph3 screenshot 14 CSL300_2301_Ph3 screenshot 15 CSL300_2301_Ph3 screenshot 16

App Changes

  • April 25, 2024 Initial release

Other Apps From ERT, INC

ERT Axsome MOMENTUM eCOA ArmMe - Mobile BYOD PD App EMPOWER (SHP643-403) ERT eCOA Handheld Alcon_CLL949-C010 Zosano Cluster Study ReViral REVC006 Biohaven_BHV3500-202 DARE-BVFREE Mirum MRX 800 MERGE Takeda_TAK-788-3001 HSV15 ENABLE (SHP643-402) TAK-660-403 U&DELIVER PSK00008 AOBiome PRB244-01 VAD00001 AstraZeneca_Scope-D1 NOVONOR_NN7415-4307 Janssen 40411813EPY2001 eDiary RSJ10333 eDiary BI1404-0036 U&ALLEVIATE GSK EPI HSV 006 BOD TH Sanofi VAT00008 Ameera-6 Aclaris ATI-1777-AD-202 AstraZeneca_CAPItello-280 ePRO BI1403-0008 BI 1403-0011 FLUTE-3 BI 1368-0098 (Lunsayil 1) CSL312_3003 15-06 eCOA CSL Seqirus V204_01 Celljuvant Study V201_03 CALM CSU / Escient Pharma Emerald-3 ICON P1-CVD-05 Enanta_EDP938104 MS202359_0002 (Xray Vision) AstraZenecaD5087C00001 SAFFRON GSK TH HSV REC 003 U & Resolution Marinus TrustTSC Janssen E.mbrace CSL Behring CSL222_3005 Landos NX-13-201 Nexus VALIANT diary (APL2-C3G-310) ARGX-117-2002 U&CHRONICLE Immorna – JCXH GSK MENABCWY-020 eDiary Icosavax ICVX-12-201 GSK 217043 eDiary Biohaven_BHV3000-312 HERMES Study App EX6018-4915 Takeda TAK-101-2001 Discover CKD Seqirus V201_07 Enanta_EDP235-101 PROSPECT-1 (Episodic Migraine) EDiary Abliva Falcon Study Reata CYPRESS 901-C-2102 PROSPECT-2 IMVT-1401-2401 U & Sunrise Roche WP44714 REIMAGINE 2 Study App TN-201-0009_MyPEAK-1 Janssen E.ngage CSL Seqirus V205_01 ICON P1-COPD-04-INT Novartis CSEG101AIC05 EP-547-201 (PACIFIC) OM Pharma BV-2020/09 - EAGLE BLOC / SBC007C401 Aclaris_ATI-450-PSA-201 Icosavax ICVX-12-101 REVERXaL CSL Behring CSL222_3002 Roche BP44474 DF6215-001 TT420C2308 / FIRST-308 Upstream Bio VIBRANT Takeda TAK-755-3002 Escient EP-262-202 MK5684-003 JSP-CP-011 MK5684-004 JNJ_80202135EBF3001 Janssen ICONIC AstraZeneca D9800C00001 Bladder Diary – VBM-100-U22 Astellas 2693-CL-0310 CLARITY-Gastric 01 REIMAGINE 4 Study App Janssen ADVANCE 2 D798EC00001 Janssen_77242113UCO2001 Eli Lilly J2A-MC-GZGV JNJ_80202135FNAIT3001 U31402-A-U102 Daiichi Sankyo Janssen 61186372NSC2007 COCOON BI 1368-0130 (Lunsayil LTE) Pacira 006-C-301 eCOA RESTORATiVE303 Study REIMAGINE 1 Study App Teva_TV56286-NDG-20039 Janssen Gus PUC3001 AP43CP03 REIMAGINE 3 Study App MK5684-01A TALENZA C3441061